-

Eurofins Environment Testing Adds Omicron Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Environment Testing adds Omicron variant detection capabilities to its commercially available SARS-CoV-2 test portfolio. The Omicron variant has been identified as a ‘variant of concern’ by the World Health Organization (WHO) due to the high number of mutations in the spike protein and indications of high transmissibility.

The monitoring of wastewater, environmental surface, air and worn mask testing, available as part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs, provides an early warning of the presence of SARS-CoV-2 and its variants amongst large populations or at a given site. This provides crucial information for monitoring viral spread and allows for relevant containment measures to be put in place to avoid an outbreak of the disease even before symptom onset.

Eurofins Environment Testing is able to detect all known SARS-CoV-2 variants in wastewater, air, environmental surfaces and worn masks. Utilizing single point mutations in RT-qPCR, the currently dominant Delta variant can be distinguished from other variants including the new Omicron variant.

For more information, visit EurofinsUS.com/Env.

About Eurofins Environment Testing America
The Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring, and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities.

About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Brian Williams
ir@eurofins.com

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

Brian Williams
ir@eurofins.com

More News From Eurofins Scientific

Eurofins Supplement Testing and the Eurofins Assurance Network Join SuppCo’s TrustScore® Ranking With Industry-leading Supplement Certifications

MADISON, Wis.--(BUSINESS WIRE)--Eurofins Supplement Testing and the Eurofins Assurance network are pleased to announce that their Certified Dietary Supplement and Clean Sport Certified programs are now incorporated into SuppCo’s TrustScore® supplement quality rating system. This integration strengthens Eurofins Supplement Testing and Eurofins Assurance’s role in third‑party supplement verification and enhances TrustScore® as a comprehensive benchmark, giving brands greater visibility in a marke...

Eurofins Announces the Cancellation of 6.163M Repurchased Shares

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the Company’s share capital, that were repurchased as part of its share buyback programmes, which began in October 2022. The cancellation of shares is in line with, among other objectives, the Company’s intention to reduce the share capital as authorised by shareho...

Eurofins Scientific SE: Director/PDMR Shareholding

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the per...
Back to Newsroom